Fingerprint
Dive into the research topics of 'Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials
for the FLASH (Follicular Lymphoma Analysis of Surrogacy Hypothesis) Group
Research output: Contribution to journal › Article › peer-review